Sequana Medical N.V. Logo

Sequana Medical N.V.

Develops implantable medical devices for treating drug-resistant fluid overload.

SEQUA | BR

Overview

Corporate Details

ISIN(s):
BE0974340722
LEI:
8755009AN12Y4PEOII07
Country:
Belgium
Address:
Kortrijksesteenweg 1112 B 102, 9051 Gent

Description

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 18:30
2025-11-13 Transparency Notification BlackRock.pdf
English 284.9 KB
2025-11-24 18:30
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (24 November 20…
English 296.1 KB
2025-11-24 18:30
Sequana Medical -- Transparency Notification PR BlackRock (NL) (24 November 202…
Dutch 311.7 KB
2025-11-14 18:00
Sequana Medical -- Fifth GEM Subscription -- Closing PR (ENG) 14 November 2025.…
English 276.3 KB
2025-11-14 18:00
Sequana Medical -- Fifth GEM Subscription -- Closing PR (NL) 14 November 2025.p…
Dutch 289.5 KB
2025-08-14 18:00
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
English 289.7 KB
2025-08-14 18:00
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
Dutch 317.1 KB
2025-08-07 18:00
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
English 232.0 KB
2025-08-07 18:00
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Dutch 252.2 KB
2025-07-28 18:00
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
English 287.8 KB
2025-07-28 18:00
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
Dutch 314.8 KB
2025-07-22 18:00
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
English 270.9 KB
2025-07-22 18:00
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Dutch 296.4 KB
2025-07-09 18:00
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (9 July 2025).p…
English 706.3 KB
2025-07-09 18:00
Sequana Medical -- Transparency Notification PR BlackRock (NL) (9 July 2025).pdf
Dutch 711.7 KB

Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sequana Medical N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-06-04 Fin-2K BV Executive member Buy 16,000 N/A
2021-05-27 Crosbie Ian Board Buy 32,000 N/A
2020-09-07 Fin-2K BV Executive member Buy 20,036 N/A
2020-09-04 Crosbie Ian Board Buy 40,073 N/A
2019-06-06 wim ottevaere Board Buy 4,000 25,600.00 EUR
2019-03-29 Fin-2K BV Executive member Buy 20,383 N/A
2019-03-06 Crosbie Ian Board Buy 40,766 N/A
2019-02-26 Chauvineau Pierre Board Buy 10,192 N/A
2019-02-13 wim ottevaere Board Buy 7,000 49,345.10 EUR

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based hydrogels to control bleeding in surgical procedures.
Japan
7777
aap Implantate AG Logo
Develops, manufactures, and markets implants for the treatment of bone fractures.
Germany
AAQ1
AcouSort AB Logo
Develops acoustofluidic solutions for automated biological sample processing.
Sweden
ACOU
Adagio Medical Holdings, Inc. Logo
Develops cryoablation technologies for treating cardiac arrhythmias like VT.
United States of America
ADGM
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for surgery and woundcare.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops immunotherapeutic devices to deplete exosomes and viruses from the blood.
United States of America
AEMD
Affluent Medical Logo
Develops minimally invasive implants for structural heart disease and urology.
France
AFME
AIOBIO Co., Ltd. Logo
Develops AI-driven diagnostic platforms and imaging devices for dental care.
South Korea
447690
Airway Medix S.A. Logo
Develops single-use medical devices for mechanically ventilated patients.
Poland
AWM
ALIGN TECHNOLOGY INC Logo
Designs and manufactures clear aligners, intraoral scanners, and digital services.
United States of America
ALGN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.